EA200401432A1 - Сложноэфирные производные декагидроизохинолин-3-карбоновой кислоты в качестве анальгетиков - Google Patents
Сложноэфирные производные декагидроизохинолин-3-карбоновой кислоты в качестве анальгетиковInfo
- Publication number
- EA200401432A1 EA200401432A1 EA200401432A EA200401432A EA200401432A1 EA 200401432 A1 EA200401432 A1 EA 200401432A1 EA 200401432 A EA200401432 A EA 200401432A EA 200401432 A EA200401432 A EA 200401432A EA 200401432 A1 EA200401432 A1 EA 200401432A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- difesticiative
- decahydroisohinolin
- analhetics
- derivatives
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Настоящее изобретение касается соединений формулы (I). Настоящее изобретение также касается применения соединения формулы (I) для изготовления лекарственного средства для лечения неврологических нарушений. Кроме того, настоящее изобретение касается применения соединения формулы (I) для изготовления лекарственного средства для лечения боли или мигрени.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37612002P | 2002-04-26 | 2002-04-26 | |
| PCT/US2003/010466 WO2003091243A1 (en) | 2002-04-26 | 2003-04-14 | Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200401432A1 true EA200401432A1 (ru) | 2005-04-28 |
| EA009526B1 EA009526B1 (ru) | 2008-02-28 |
Family
ID=29270765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200401432A EA009526B1 (ru) | 2002-04-26 | 2003-04-14 | Сложноэфирные производные декагидроизохинолин-3-карбоновой кислоты в качестве анальгетиков |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7247644B2 (ru) |
| EP (1) | EP1511741B1 (ru) |
| JP (2) | JP2005529892A (ru) |
| KR (1) | KR100757787B1 (ru) |
| CN (1) | CN100436446C (ru) |
| AU (1) | AU2003226277B2 (ru) |
| BR (1) | BR0308911A (ru) |
| CA (1) | CA2480026C (ru) |
| DK (1) | DK1511741T3 (ru) |
| EA (1) | EA009526B1 (ru) |
| ES (1) | ES2398225T3 (ru) |
| IL (1) | IL164773A (ru) |
| MX (1) | MXPA04009857A (ru) |
| NZ (1) | NZ535245A (ru) |
| PT (1) | PT1511741E (ru) |
| SI (1) | SI1511741T1 (ru) |
| WO (1) | WO2003091243A1 (ru) |
| ZA (1) | ZA200409552B (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1511741T3 (da) * | 2002-04-26 | 2013-01-21 | Lilly Co Eli | Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika |
| CA2686816A1 (en) | 2007-01-16 | 2008-07-24 | The Johns Hopkins University | Use of various glutamate receptor antagonists for delaying or preventing platelet activity or for treating or preventing a thrombotic disease or disorder |
| AU2021299570A1 (en) * | 2020-07-02 | 2023-02-23 | Sea Pharmaceuticals Llc | Pharmaceutical compositions of 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and ester derivatives thereof |
| KR20240022544A (ko) * | 2021-06-09 | 2024-02-20 | 프로니라스 코포레이션 | 신경 작용제-유도 발작을 치료하는 방법 |
| WO2023130008A2 (en) * | 2022-01-01 | 2023-07-06 | Sea Pharmaceuticals Llc | Pharmaceutical compositions of 6-(2-(2h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid and derivatives thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK406686D0 (da) * | 1986-08-26 | 1986-08-26 | Hans Bundgaard | Carboxylsyrederivater |
| US4902695A (en) * | 1989-02-13 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| US5284957A (en) | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| US5356902A (en) | 1992-11-06 | 1994-10-18 | Eli Lilly And Company | Decahydroisoquinoline compounds as excitatory amino acid receptor antagonists |
| US5446051A (en) | 1994-05-31 | 1995-08-29 | Eli Lilly And Company | Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitatory amino acid receptor antagonists |
| US5767117A (en) | 1994-11-18 | 1998-06-16 | The General Hospital Corporation | Method for treating vascular headaches |
| WO1998045270A1 (en) | 1997-04-07 | 1998-10-15 | Eli Lilly And Company | Pharmacological agents |
| ATE240299T1 (de) | 1999-07-06 | 2003-05-15 | Lilly Co Eli | Diester prodrugs von decahydroischinoline-3- carbonsäure |
| CN1230174C (zh) | 1999-07-06 | 2005-12-07 | 伊莱利利公司 | 治疗偏头痛的选择性iGluR5受体拮抗剂 |
| EP1257545A1 (en) | 1999-12-22 | 2002-11-20 | Eli Lilly And Company | SELECTIVE iGLUR 5? RECEPTOR ANTAGONISTS |
| US6953805B2 (en) | 2001-01-05 | 2005-10-11 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| MXPA03005982A (es) | 2001-01-05 | 2003-09-10 | Lilly Co Eli | Antagonistas de receptores de aminoacidos excitadores. |
| AU2001298029A1 (en) | 2001-01-05 | 2003-04-01 | Eli Lilly And Company | Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases |
| US6855725B2 (en) | 2001-01-05 | 2005-02-15 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| AU2003219955A1 (en) | 2002-03-22 | 2003-10-13 | Eli Lilly And Company | Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists |
| DK1511741T3 (da) * | 2002-04-26 | 2013-01-21 | Lilly Co Eli | Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika |
-
2003
- 2003-04-14 DK DK03747269.3T patent/DK1511741T3/da active
- 2003-04-14 ES ES03747269T patent/ES2398225T3/es not_active Expired - Lifetime
- 2003-04-14 KR KR1020047017143A patent/KR100757787B1/ko not_active Expired - Fee Related
- 2003-04-14 CA CA2480026A patent/CA2480026C/en not_active Expired - Fee Related
- 2003-04-14 PT PT37472693T patent/PT1511741E/pt unknown
- 2003-04-14 US US10/511,452 patent/US7247644B2/en not_active Expired - Fee Related
- 2003-04-14 MX MXPA04009857A patent/MXPA04009857A/es active IP Right Grant
- 2003-04-14 SI SI200332227T patent/SI1511741T1/sl unknown
- 2003-04-14 CN CNB038094606A patent/CN100436446C/zh not_active Expired - Fee Related
- 2003-04-14 EA EA200401432A patent/EA009526B1/ru not_active IP Right Cessation
- 2003-04-14 EP EP03747269A patent/EP1511741B1/en not_active Expired - Lifetime
- 2003-04-14 JP JP2003587801A patent/JP2005529892A/ja active Pending
- 2003-04-14 WO PCT/US2003/010466 patent/WO2003091243A1/en not_active Ceased
- 2003-04-14 NZ NZ535245A patent/NZ535245A/en not_active IP Right Cessation
- 2003-04-14 BR BR0308911-8A patent/BR0308911A/pt active Search and Examination
- 2003-04-14 AU AU2003226277A patent/AU2003226277B2/en not_active Ceased
-
2004
- 2004-10-21 IL IL164773A patent/IL164773A/en not_active IP Right Cessation
- 2004-11-25 ZA ZA200409552A patent/ZA200409552B/xx unknown
-
2010
- 2010-06-23 JP JP2010142881A patent/JP2010235623A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR0308911A (pt) | 2005-01-04 |
| DK1511741T3 (da) | 2013-01-21 |
| PT1511741E (pt) | 2013-02-05 |
| KR20040102171A (ko) | 2004-12-03 |
| WO2003091243A8 (en) | 2005-03-31 |
| EP1511741B1 (en) | 2012-12-26 |
| MXPA04009857A (es) | 2004-12-07 |
| AU2003226277A1 (en) | 2003-11-10 |
| JP2010235623A (ja) | 2010-10-21 |
| EP1511741A1 (en) | 2005-03-09 |
| AU2003226277B2 (en) | 2009-03-26 |
| IL164773A (en) | 2011-08-31 |
| KR100757787B1 (ko) | 2007-09-11 |
| CA2480026C (en) | 2011-06-07 |
| NZ535245A (en) | 2007-11-30 |
| US20050256155A1 (en) | 2005-11-17 |
| EA009526B1 (ru) | 2008-02-28 |
| WO2003091243A1 (en) | 2003-11-06 |
| ES2398225T3 (es) | 2013-03-14 |
| CN1649862A (zh) | 2005-08-03 |
| IL164773A0 (en) | 2005-12-18 |
| US7247644B2 (en) | 2007-07-24 |
| CN100436446C (zh) | 2008-11-26 |
| CA2480026A1 (en) | 2003-11-06 |
| SI1511741T1 (sl) | 2013-02-28 |
| JP2005529892A (ja) | 2005-10-06 |
| ZA200409552B (en) | 2006-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300933I2 (nl) | Letermovir | |
| SE0303180D0 (sv) | Novel compounds | |
| EA200301216A1 (ru) | Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания | |
| SE0302232D0 (sv) | Novel Compounds | |
| BR0311494A (pt) | Novos indóis substituìdos | |
| WO2004013120A8 (en) | Novel benzodioxoles | |
| ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
| CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
| EA200200716A1 (ru) | Арилконденсированные азаполициклические соединения | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
| EA200300829A1 (ru) | Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6 | |
| MX2008000255A (es) | Activadores de urea glucocinasa. | |
| CY1111733T1 (el) | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri | |
| BRPI0412999A (pt) | 2-aminotetralina substituìda para tratamento de depressão | |
| EA200301142A1 (ru) | Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
| DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
| EA200600605A1 (ru) | Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств | |
| MXPA05010020A (es) | Derivados de oxamida. | |
| DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| IL172290A0 (en) | Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain | |
| DE602006014022D1 (de) | 5-substituierte indol-2-carbonsäureamidderivate | |
| EA200600115A1 (ru) | Производные 2-аминобензойной кислоты | |
| PE20040975A1 (es) | Derivados de aril- y heteroarilmorfolina | |
| WO2003091243A8 (en) | Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |